Rheumocam

< Back

Rheumocam is a modern, non-steroidal, anti-inflammatory drug which is licensed for use in dogs, cats and horses. It is particularly used for conditions associated with pain, swelling or reduced mobility of bones, joints and muscles. It is sometimes also prescribed to reduce the inflammation and discomfort which occurs following an injury or surgical procedure. It is available as a liquid for dogs, cats and horses and also tablets for dogs. Rheumocam is normally given once daily, with the first dose being a double "loading" dose. (This dose is sometimes given by the vet by injection.) It is important to follow the correct dose as and not to overdose.

Read More...

Filter the products displayed:

Rheumocam 1.5 mg/ml oral suspension for dogs

Presentation

Oral suspension. Each ml contains Meloxicam 1.5 mg and Sodium benzoate 5 mg.

Uses

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) for the use of alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.

Dosage and administration

Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.

Particular care should be taken with regard to the accuracy of dosing.

Shake well before use.

To be administered mixed with food.

The suspension can be given using the Rheumocam measuring syringe provided in the package.

The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight). Thus for the first day, twice the maintenance volume will be required.

Dosing procedure using the measuring syringe

Step 1: Before using Rheumocam for the very first time ensure that you have the bottle, circular plastic insert and syringe.

Step 2: Place the circular plastic insert into the neck of the bottle and push down until securely in place. Once in place the insert will not need to be removed.

Step 3: Replace the cap onto the bottle and shake it well. Take off the bottle cap and attach the dosing syringe to the bottle by gently pushing the end into the hole.

Step 4: Turn the bottle with the syringe in place upside down and slowly withdraw the plunger until the required dose is evident.

Step 5: Turn the bottle/syringe the right way up and with a twisting movement separate the syringe from the bottle.

Step 6: Push the plunger until all contents of the syringe have been dispensed onto the food.

A clinical response is normally seen within 3 - 4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

Contra-indications, warnings, etc

Do not use in pregnant or lactating animals.

Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do not use in dogs less than 6 weeks of age.

If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.

In the case of overdosage symptomatic treatment should be initiated.

Operator warnings

People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

General precautions

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. For animal treatment only. Keep out of the reach and sight of children.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Shelf-life of the veterinary medicinal product as packaged for sales: 2 years

Shelf-life after first opening the immediate packaging: 6 months

Legal category

POM-V

Packaging Quantities

15 (HDPE), 42, 100 or 200 ml polyethylene bottle with a tamper resistant child proof closure and a polypropylene measuring syringe. Not all pack sizes may be marketed.

Marketing authorisation number

EU/2/07/078/001-004.

Rheumocam 15mg/ml Oral Suspension for Horses

Presentation

Oral suspension. Each ml contains 15mg of meloxicam and 5mg sodium benzoate.

Uses

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) for the of alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in horses.

Dosage and administration

To be administered either mixed with food or directly into the mouth at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days. This is equivalent to 1 ml of Rheumocam per 25 kg body weight of horse. For example, a horse weighing 400 kg will receive 16 ml of Rheumocam, a horse weighing 500 kg will receive 20 ml of Rheumocam, and a horse weighing 600 kg will receive 24 ml of Rheumocam.

In case the product is mixed with food, it should be added to a small quantity of food, prior to feeding.

The suspension should be given using the Rheumocam measuring syringe provided in the package. The syringe fits onto the bottle and has a bodyweight / ml scale.

Shake well before use. Avoid introduction of contamination during use.

Contra-indications, warnings, etc

Do not use in pregnant or lactating mares.

Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do not use in horses less than 6 weeks of age.

Withdrawal periods

Meat and offal: 3 days.

Not authorised for use in lactating animals producing milk for human consumption.

Adverse reactions

Isolated cases of adverse reactions typically associated with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) were observed in clinical trials (slight urticaria, diarrhoea). Symptoms were reversible.

If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.

Precautions for use in animals

If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.

Precautions to be taken by the person administering the product

People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show this package leaflet or the label to the physician.

Interactions

Do not administer concurrently with glucocorticoids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.

Overdose

In the case of overdose symptomatic treatment should be initiated.

Pharmaceutical precautions

Keep out of the reach and sight of children.

This veterinary medicinal product does not require any special storage conditions.

After administration of the veterinary medicinal product, close the bottle by replacing the cap, wash the measuring syringe with warm water and let it dry.

Do not use after the expiry date (EXP) stated on the carton and the bottle.

Shelf life after first opening of the container: 3 months.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Legal category

POM-V

Packaging Quantities

100 or 250 ml bottle with a measuring syringe.

Further information

Nil

Marketing authorisation number

EU/2/07/078/009 100 ml.

EU/2/07/078/010 250 ml.

Rheumocam 1mg and 2.5mg Tablets

Presentation

Pale-yellow, single-scored, pork flavoured chewable tablets containing 1mg or 2.5mg meloxicam.

Uses

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.

Dosage and administration

Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.

Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.

Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog, or a 25 kg body weight dog respectively. Each chewable tablet can be halved for accurate dosing according to the individual body weight of the animal. Rheumocam chewable tablets can be administered with or without food, are flavoured and are taken by most dogs voluntarily.

The use of Rheumocam oral suspension for dogs may be considered for an even more precise dosing. For dogs weighing less than 4 kg the use of Rheumocam oral suspension for dogs is recommended.

A clinical response is normally seen within 3 – 4 days. Treatment should be discontinued after 10 days if no clinical improvement is apparent.

Contra-indications, warnings, etc

Do not use in pregnant or lactating animals.

Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.

Do not use in dogs less than 6 weeks of age or less than 4 kg body weight.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Adverse reactions

Typical adverse drug reactions of non-steroidal anti-inflammatory drugs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

If you notice any serious effects or other effects not mentioned in this datasheet, please inform your veterinary surgeon.

Precautions for use in animals

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.

Precautions to be taken by the person administering the product

People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show this package leaflet or the label to the physician.

Interactions

Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Rheumocam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.

Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.

Overdose

In the case of overdosage symptomatic treatment should be initiated.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Legal category

POM-V

Packaging Quantities

20 or 100 tablets

Not all pack sizes may be marketed.

Marketing authorisation number

EU/2/07/078/005-008.

Need help or advice? Contact us:

  • Freephone: 0800 084 2608
  • Mon - Fri: 8:30am - 7:00pm
  • Sat: 10:00am - 3:00pm
  • Email: support@viovet.co.uk

All prices include VAT where applicable.

No Reviews For Rheumocam

Have you tried Rheumocam? Be the first to write a review!

Write a Review!
AJAX:/family.ajax?mode=tab_delivery

Ask your own question about Rheumocam

There are currently no questions for Rheumocam, be the first to ask one!





Thank you for your question regarding Rheumocam, you will receive an email when a member of our team provides an answer.